A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) ...

Please provide your email address to receive an email when new articles are posted on . The study will evaluate whether two multicancer early detection tests improve early detection of 10 solid tumors ...

Want to B-positive about your health? Johns Hopkins researchers have developed a cutting-edge blood test that can detect signs of cancer three years before any symptoms surface. The breakthrough could ...

(RTTNews) - Exact Sciences Corp. (EXAS) announced the U.S. launch of Cancerguard™, its multi-cancer early detection or MCED blood test, now available as a laboratory-developed test or LDT. Cancerguard ...

Angus is STAT’s cancer reporter. Marissa, when not working as an intern, studies extracellular vesicles in the brain in her Ph.D. research. Angus Chen covers all issues broadly related to cancer ...

A routine blood test may be able to detect cancer more than three years before diagnosis, a new study suggests. Using a multicancer early detection test, they identified tumor-derived genetic ...